Literature DB >> 15336511

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

Michael F Green1, Keith H Nuechterlein, James M Gold, Deanna M Barch, Jonathan Cohen, Susan Essock, Wayne S Fenton, Fred Frese, Terry E Goldberg, Robert K Heaton, Richard S E Keefe, Robert S Kern, Helena Kraemer, Ellen Stover, Daniel R Weinberger, Steven Zalcman, Stephen R Marder.   

Abstract

To stimulate the development of new drugs for the cognitive deficits of schizophrenia, the National Institute of Mental Health (NIMH) established the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative. This article presents an overview of decisions from the first MATRICS consensus conference. The goals of the meeting were to 1) identify the cognitive domains that should be represented in a consensus cognitive battery and 2) prioritize key criteria for selection of tests for the battery. Seven cognitive domains were selected based on a review of the literature and input from experts: working memory, attention/vigilance, verbal learning and memory, visual learning and memory, reasoning and problem solving, speed of processing, and social cognition. Based on discussions at this meeting, five criteria were considered essential for test selection: good test-retest reliability, high utility as a repeated measure, relationship to functional outcome, potential response to pharmacologic agents, and practicality/tolerability. The results from this meeting constitute the initial steps for reaching a consensus cognitive battery for clinical trials in schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15336511     DOI: 10.1016/j.biopsych.2004.06.023

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  255 in total

1.  Patients with schizophrenia demonstrate inconsistent preference judgments for affective and nonaffective stimuli.

Authors:  Gregory P Strauss; Benjamin M Robinson; James A Waltz; Michael J Frank; Zuzana Kasanova; Ellen S Herbener; James M Gold
Journal:  Schizophr Bull       Date:  2010-05-19       Impact factor: 9.306

2.  The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.

Authors:  Eri Nakagami; Maanse Hoe; John S Brekke
Journal:  Schizophr Bull       Date:  2010-05-12       Impact factor: 9.306

Review 3.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

4.  Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapy.

Authors:  Shaun M Eack; Amber L Bahorik; Susan S Hogarty; Deborah P Greenwald; Maralee Y Litschge; Carla A Mazefsky; Nancy J Minshew
Journal:  J Autism Dev Disord       Date:  2013-09

5.  The Change in Facial Emotion Recognition Ability in Inpatients with Treatment Resistant Schizophrenia After Electroconvulsive Therapy.

Authors:  Mihriban Dalkıran; Akif Tasdemir; Tamer Salihoglu; Murat Emul; Alaattin Duran; Mufit Ugur; Ruhi Yavuz
Journal:  Psychiatr Q       Date:  2017-09

Review 6.  CNTRICS final task selection: control of attention.

Authors:  Keith H Nuechterlein; Steven J Luck; Cindy Lustig; Martin Sarter
Journal:  Schizophr Bull       Date:  2009-01       Impact factor: 9.306

7.  The reliability and validity of the MATRICS functional assessment battery.

Authors:  Dawn I Velligan; Megan Fredrick; Jim Mintz; Xueying Li; Maureen Rubin; Sanjay Dube; Smita N Deshpande; Jitendra K Trivedi; Shiv Gautam; Ajit Avasthi; Robert S Kern; Stephen R Marder
Journal:  Schizophr Bull       Date:  2013-11-09       Impact factor: 9.306

8.  Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Josette G Harris; Ann Olincy; Keeran Maharajh; Eugene Kronberg; Lindsay C Eichman; Emma Lyons; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

9.  Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches.

Authors:  Keith H Nuechterlein; Joseph Ventura; Kenneth L Subotnik; Jacqueline N Hayata; Alice Medalia; Morris D Bell
Journal:  Am J Psychiatr Rehabil       Date:  2014-07

10.  Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.

Authors:  Karin S Walsh; Jennifer Janusz; Pamela L Wolters; Staci Martin; Bonita P Klein-Tasman; Mary Anne Toledo-Tamula; Heather L Thompson; Jonathan M Payne; Kristina K Hardy; Peter de Blank; Claire Semerjian; Laura Schaffner Gray; Sondra E Solomon; Nicole Ullrich
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.